Olaris featured in BiopharmaTrend Q&A article, "Hacking Metabolomics With AI To Improve Clinical Research"

"Hacking Metabolomics With AI To Improve Clinical Research" Check out Olaris CEO, Dr. Liz O'Day's, recent Q&A interview with BiopharmaTrend. Dr. O'Day explains how Olaris combines metabolomics, NMR and machine learning to further precision medicine. Read the full article here!

Olaris, Inc

35 Gatehouse Drive

Waltham, Massachusetts

02451

e: info@olarisBoR.com

  • Grey LinkedIn Icon
  • Grey Facebook Icon
  • Twitter

© 2021 Olaris, Inc